Factors affecting the occurrence of psychotic symptoms in chronic methamphetamine users

References

• United Nations Office on Drugs and Crime. 2017 Global Synthetic Drugs Assessment. https://www.unodc.org/documents/scientific/Global_Drugs_Assessment_2017.pdf, 2017.
   Google Scholar
• Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, Iguchi M. Psychiatric symptoms in methamphetamine users. Am J Addict. 2004; 13:181–90. doi:10.1080/10550490490436055.
   PubMed Web of Science ®Google Scholar
• London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004; 61:73–84. doi:10.1001/archpsyc.61.1.73.
   PubMed Web of Science ®Google Scholar
• Sulaiman AH, Said MA, Habil MH, Rashid R, Siddiq A, Guan NC, Midin M, Nik Jaafar NR, Sidi H, Das S. The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia. Compr Psychiatry. 2014; 55: Suppl S89–S94. doi:10.1016/j.comppsych.2013.01.003.
   PubMed Web of Science ®Google Scholar
• Grant KM, LeVan TD, Wells SM, Li M, Stoltenberg SF, Gendelman HE, Carlo G, Bevins RA. Methamphetamine-associated psychosis. J Neuroimmune Pharmacol. 2012; 7:113–39. doi:10.1007/s11481-011-9288-1.
   PubMed Web of Science ®Google Scholar
• Sato M. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann NY Acad Sci. 1992; 654:160–70. doi:10.1111/j.1749-6632.1992.tb25965.x.
   PubMed Web of Science ®Google Scholar
• McKetin R, McLaren J, Lubman DI, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction. 2006; 101:1473–1478. doi:10.1111/j.1360-0443.2006.01496.x.
   PubMed Web of Science ®Google Scholar
• McKetin R, Lubman DI, Najman JM, Dawe S, Butterworth P, Baker AL. Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study. Addiction. 2014; 109:798–806. doi:10.1111/add.12474.
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R. Clinical course and outcomes of methamphetamine-dependent adults with psychosis. J Subst Abuse Treat. 2008; 35:445–50. doi:10.1016/j.jsat.2007.12.004.
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson RA. Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev. 2009; 29:12–20. doi:10.1111/j.1465-3362.2009.00081.x.
   Web of Science ®Google Scholar
• Chen CK, Lin SK, Sham PC, Ball D, Loh el W, Murray RM. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet. 2005; 136B:87–91. doi:10.1002/ajmg.b.30187.
   PubMed Web of Science ®Google Scholar
• Salo R, Nordahl TE, Leamon MH, Natsuaki Y, Moore CD, Waters C, Carter CS. Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse. Psychiatry Res. 2008; 157:273–7. doi:10.1016/j.psychres.2007.04.018.
   PubMed Web of Science ®Google Scholar
• Chen CK, Lin SK, Sham PC, Ball D, Loh EW, Hsiao CC, Chiang YL, Ree SC, Lee CH, Murray RM. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med. 2003; 33:1407–14. doi:10.1017/S0033291703008353.
   PubMed Web of Science ®Google Scholar
• Kittirattanapaiboon P, Mahatnirunkul S, Booncharoen H, Thummawomg P, Dumrongchai U, Chutha W. Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug Alcohol Rev. 2010; 29:456–61. doi:10.1111/j.1465-3362.2010.00196.x.
   PubMed Web of Science ®Google Scholar
• Ding Y, Lin H, Zhou L, Yan H, He N. Adverse childhood experiences and interaction with methamphetamine use frequency in the risk of methamphetamine-associated psychosis. Drug Alcohol Depend. 2014; 142:295–300. doi:10.1016/j.drugalcdep.2014.06.042.
   PubMed Web of Science ®Google Scholar
• McKetin R, Hickey K, Devlin K, Lawrence K. The risk of psychotic symptoms associated with recreational methamphetamine use. Drug Alcohol Rev. 2010; 29:358–63. doi:10.1111/j.1465-3362.2009.00160.x.
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Kane JM, Alvir J. Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology (Berl).). 1987; 91:415–33. doi:10.1007/bf00216006.
   PubMed Web of Science ®Google Scholar
• Tsuang MT, Simpson JC, Kronfol Z. Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history. Arch Gen Psychiatry. 1982; 39:141–7. doi:10.1001/archpsyc.1982.04290020013003.
   PubMed Web of Science ®Google Scholar
• Vincent N, Schoobridge J, Ask A, Allsop S, Ali R. Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia. Drug Alcohol Rev. 1998; 17:187–95. doi:10.1080/09595239800186991.
   PubMed Web of Science ®Google Scholar
• Christian DR, Huber A, Brecht ML, McCann MJ, Marinelli-Casey P, Lord RH, Reiber C, Lu TH, Methamphetamine Treatment P, Galloway GP. Methamphetamine users entering treatment: characteristics of the methamphetamine treatment project sample. Subst Use Misuse. 2007; 42:2207–22.
   PubMed Web of Science ®Google Scholar
• McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA Psychiatry. 2013; 70:319–24. doi:10.1001/jamapsychiatry.2013.283.
   PubMed Web of Science ®Google Scholar
• Bramness JG, Gundersen OH, Guterstam J, Rognli EB, Konstenius M, Loberg EM, Medhus S, Tanum L, Franck J. Amphetamine-induced psychosis–a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry. 2012; 12:221–221. doi:10.1186/1471-244X-12-221.
   PubMed Web of Science ®Google Scholar
• Lineberry TW, Bostwick JM. Methamphetamine abuse: a perfect storm of complications. Mayo Clin Proc. 2006; 81:77–84. doi:10.4065/81.1.77.
   PubMed Web of Science ®Google Scholar
• Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiatry. 2004; 185:196–204. doi:10.1192/bjp.185.3.196.
   PubMed Web of Science ®Google Scholar
• Bell DS. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry. 1973; 29:35–40. doi:10.1001/archpsyc.1973.04200010020003.
   PubMed Web of Science ®Google Scholar
• Ujike H, Sato M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann N Y Acad Sci. 2004; 1025:279–287. doi:10.1196/annals.1316.035.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Kamijo A, Miyakawa T, Endo K, Yabana T, Kishimoto H, Okudaira K, Iseki E, Sakai T, Kosaka K. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction. 2002; 97:809–817. doi:10.1046/j.1360-0443.2002.00143.x.
   PubMed Web of Science ®Google Scholar
• Zhang C, Luo T, Liu L, Dong H, Hao W. Prevalence rates of personality disorder and its association with methamphetamine dependence in compulsory treatment facilities in China. Front Psychiatry. 2018; 9:698–698.
   PubMed Web of Science ®Google Scholar
• Koeneman MM, van Lint FHM, van Kuijk SMJ, Smits LJM, Kooreman LFS, Kruitwagen R, Kruse AJ. A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters. Hum Pathol. 2017; 59:62–69. doi:10.1016/j.humpath.2016.09.012.
   PubMed Web of Science ®Google Scholar
• Fahrmeir L, Kneib T, Lang S, Marx B. Regression: models, methods and applications. Berlin: Springer Science & Business Media, 2013.
   Google Scholar
• Hsieh JH, Stein DJ, Howells FM. The neurobiology of methamphetamine induced psychosis. Front Hum Neurosci. 2014; 8:537–537.
   PubMed Web of Science ®Google Scholar
• Rognli EB, Hakansson A, Berge J, Bramness JG. Does the pattern of amphetamine use prior to incarceration predict later psychosis?–a longitudinal study of amphetamine users in the Swedish criminal justice system. Drug Alcohol Depend. 2014; 143:219–224. doi:10.1016/j.drugalcdep.2014.07.037.
   PubMed Web of Science ®Google Scholar
• Buck JM, Siegel JA. The effects of adolescent methamphetamine exposure. Front Neurosci. 2015; 9:151.
   PubMed Web of Science ®Google Scholar
• Ye T, Pozos H, Phillips TJ, Izquierdo A. Long-term effects of exposure to methamphetamine in adolescent rats. Drug Alcohol Depend. 2014; 138:17–23. doi:10.1016/j.drugalcdep.2014.02.021.
   PubMed Web of Science ®Google Scholar
• Giedd JN, Raznahan A, Alexander-Bloch A, Schmitt E, Gogtay N, Rapoport JL. Child psychiatry branch of the National Institute of Mental Health longitudinal structural magnetic resonance imaging study of human brain development. Neuropsychopharmacol. 2015; 40:43–49. doi:10.1038/npp.2014.236.
   PubMed Web of Science ®Google Scholar
• Sato M, Chen CC, Akiyama K, Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry. 1983; 18:429–440.
   PubMed Web of Science ®Google Scholar
• O'Neil ML, Kuczenski R, Segal DS, Cho AK, Lacan G, Melega WP. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge. Synapse. 2006; 60:465–473. doi:10.1002/syn.20320.
   PubMed Web of Science ®Google Scholar
• McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure. Neuropharmacology. 2015; 93:146–154. doi:10.1016/j.neuropharm.2015.01.013.
   PubMed Web of Science ®Google Scholar
• Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. Plos Med. 2005; 2:e141– 433. doi:10.1371/journal.pmed.0020141.
   PubMed Web of Science ®Google Scholar
• Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev. 2007; 17:275–297. doi:10.1007/s11065-007-9031-0.
   PubMed Web of Science ®Google Scholar
• Dean AC, Groman SM, Morales AM, London ED. An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacol. 2013; 38:259–274. doi:10.1038/npp.2012.179.
   PubMed Web of Science ®Google Scholar
• Simon SL, Dean AC, Cordova X, Monterosso JR, London ED. Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. J Stud Alcohol Drugs. 2010; 71:335–344. doi:10.15288/jsad.2010.71.335.
   PubMed Web of Science ®Google Scholar
• Phelps EA, Sharot T. How (and Why) Emotion Enhances the Subjective Sense of Recollection. Curr Dir Psychol Sci. 2008; 17:147–152. doi:10.1111/j.1467-8721.2008.00565.x.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. 2008 Global ATS Assessment. https://www.unodc.org/documents/scientific/ATS/Global-ATS-Assessment-2008-Web.pdf, 2008.
   Google Scholar